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As a  result of intensified  studies  during recent years, the number of known 
arthropod-borne  (arbor)  viruses  has  been greatly increased.  One of the most 
valuable  pieces  of knowledge  which  has  emerged  from these  studies  is  that 
many of these arbor viruses fall into dearly defined antigenic groups (1).  Al- 
though immunologic relationships  between some of them had been previously 
shown, the introduction of the group concept by Casals (2, 3) clarified and sys- 
tematized these relationships.  While cross-neutralization and complement-fixa- 
tion  tests are  also used  in  establishing  group relationships,  the  technique  of 
hemagglutination-inhibition  (HI) has provided the best method for the demon- 
stration of antigenic relationships between members of group B and, indeed, the 
extent of overlap observed by HI my  be so great as to resemble the situation 
that exists between various strains of type A influenza. As antigenic analysis by 
antibody absorption has proved fruitful in the study of the latter viruses (4-6), 
it  was  decided to apply a  similar  approach to an analysis of the relationship 
among  certain group B  arbor viruses.  The results  of some of the studies are 
the subject of the present paper. 
Materials and Methods 
Viru~es.--The  viruses used in the study are given in Table I. Their designation in subgroups 
rests on particularly  close antigenic relationships revealed by various serologic  procedures (1). 
The place and date of isolation of certain strains are given when this information is pertinent 
to the present  study. 
Immune Scra.--The sera were prepared in either rabbits or mice. Rabbits were immunized 
with one or more injections of infective virus depending upon the antibody response. Mice 
received multiple  (four or five) immunizing inoculations. With viruses which were pathogenic 
by the intraperitonesl  route,  the  first injections consisted of inactivated  virus followed by 
one or two inoculations of infective virus. Where multiple  inoculations were  required,  the 
animals were bled 7 to 10 days following the last dose. 
Hemagglu~inationdnhibition Tests.--The  preparation  of test  antigens,  removal  of non- 
specific inhibitors from sera, and performance of the tests were done as previously described 
from these laboratories  (7). The test antigens were prepared  by either  the acetone-ether  or 
sucrose-acetone extraction methods. All tests were carried out in tubes. 
Technique of Antibody Absorplion.--The absorbing virus was prepared from a 20 per cent 
homogenate  of infected suckling mouse brain made in borate-buffered saline, pH 9.3 (0.05 
M  borate-0.12  M NaCI).  The homogenate  was centrifuged  for one hour  at  11,000 R.P.~. in 
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the No. 40  rotor  of  a  Spinco  model  L  centrifuge,  the supernatant  fluid  was  recovered, 
and  various aliquots were sedimented for 2 hours at 40,000  R.l,.~r. in the same rotor.  The 
pellets were homogenized in the test serum previously diluted 1/10 in borate-saline, pH 9.0. 
The latter homogenization was carried out in thick-walled glass tubes equipped with fitted 
teflon plungers which were motor-driven, All work was carried out in ice baths. The serum- 
virus mixtures were held overnight in the cold, and the virus then removed by sedimentation 
for 2 hours at 40,000 mP.M. This final centrifugation was carried out in small (3 ml.)  tubes 
fitted into the No. 40 rotor by means of appropriate  nylon adapters.  Little difficulty was 
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encountered in removing all excess  virus provided the fluid in the bottom of the tube was 
sacrificed.  It seems probable that the relative ease with which absorbing virus was removed 
was due to the gummy nature of the virus-containing pellets which tended to trap and im- 
mobilize the  sedlmentable  constituents.  The  absorbed  and  unabsorbed  control  sera were 
then treated with kaolin, and finally, with goose cells to remove non-specific  iahibitors and 
hemagglutinins. Since the sera were in a  dilution of 1/10, an equal volume of 12.5 per cent 
kaolin suspension was used. The initial serum dilution in all HI tests was, therefore, 1/20. 
The absorption procedure found most satisfactory was to homogenize 3  mL aliquots of 
1/10 test serum with the pellets obtained from varying volumes of virus suspension. In the 
early phase of the work, an attempt was made to correlate absorbing efficiency with infective 
or HA titer, but the limited studies were not encouraging. It seems probable that the total 
amount of antigenically active, sedimentable material present can be expressed  only in terms D. H. CLARX~  23 
of its ability to combine with and remove antibody. For convenience, the amount of absorbing 
virus is expressed as grams of original infected mouse brain used to prepare the homogenate; 
this figure is calculated for 1 ml. of undiluted serum. 
It might be mentioned that attempts have been made to use virus-coated chick or goose 
erythrocytes  (plain or formol-treated) for antibody absorption, as has been done in influenza 
virus studies, but with results that were not encouraging. A reasonable explanation appears 
to be that a major portion of the antigenieally active material present in the homogenate does 
not combine with red cells, at least not to a quantitatively  favorable degree. 
EXPEI~ TMT.NTAL 
Homologous and Heterologous Absorptian Curves.--Wben an immune serum is 
absorbed with increasing  amounts of the homologous virus and the resultant 
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FIG.  1. Homologous and heterologous antibody absorption. 
a.  Homologous absorption  of West Nile (Egypt 101) and yellow fever-17 D sera. 
b. Heterologous absorption  of St. Louis with yellow fever virus. 
homologous HI titers of the serum samples are plotted against the amount of 
absorbing virus, a curve is obtained, the slope of which varies with the absorb- 
ing virus used. Although different viruses differ considerably in their capacity 
to absorb antibody, there is little or no variation between different preparations 
of the same virus. Fig. 1 a presents two curves which represent the extremes of 
homologous absorption efficiency. The Egypt 101 strain of West Nile is seen to 
be a highly efficient absorber, while excessively large amounts of the 17 D  vac- 
cine strain of yellow fever were required to effect complete antibody removal. 
Multiple absorptions with smaller amounts of virus appeared to offer no advan- 
tage and were considerably more wasteful  of serum,  virus,  and  time.  Fortu- 
nately, most of the viruses studied resembled more closely the West Nile pic- 
ture, including strains of yellow fever other than the 17 D. 
In Fig. 1 b are shown the results of heterologous absorption. In this case, the 
serum (St. Louis) was absorbed with increasing amounts of yellow fever virus 24  GROUP B  ARTHROPOD-BORNE  VIRUSES 
(JSS strain), and the resultant serum samples were tested against both the ab- 
sorbing (heterologons)  and the immunizing  (homologous)  virus. The antibodies 
detected by the yellow fever antigen were removed in a manner resembling a 
homologous absorption curve, while the St. Louis antibody curve shows a fall 
followed by a plateau which remains flat regardless  of the amount of heterolo- 
gons absorbing virus used. 
The data presented throughout the remainder of the paper were obtained by 
the use of sufficient absorbing virus to remove all detectable antibody or to reach 
the plateau area. 
Strain Homogeneity.--One of the striking observations to emerge from the 
antigenic analysis of type A influenza viruses has been the great variability of 
strains, even among those isolated during the course of a single outbreak (8). 
Since it has been our impression that group B arbor viruses exhibit considerable 
antigenic stability, it was of interest to subject this impression  to closer exam- 
ination by absorption analysis.  For this purpose,  three strains of West  Nile 
virus were selected which had been isolated at different times and from different 
countries.  The Uganda strain was the first isolate of this virus and was made by 
Smithburn and his associates  (9). The Egypt strain was isolated 10 years later 
by Melnick e~ a/. (10), while the Indian strain  was obtained recently by Work 
and coworkers (11). The first two strains were obtained from human beings and 
the third from mosquitoes. 
Comparison of the three strains  was made by absorbing immune sera pre- 
pared against the Egypt and India strains  with all three viruses and testing 
them against the three strain antigens. When a sufficient amount of any of the 
three strains was used, both sera were completely freed of all antibody (detect- 
able at the 1/20 dilution). Furthermore, the absorbing efficiencies of the three 
strains, for each serum, were quite similar, although for complete exhaustion the 
Indian strain serum required larger  amounts of the three strains than did the 
Egyptian. 
These studies thus indicate that the three strains of West Nile, despite their 
diverse origins,  are antigenically identical as judged by the absorption tech- 
nique. The only difference noted among the three was that both sera, before ab- 
sorption, gave higher HI titers when tested against the Uganda strain antigen 
than were realized with either the Egyptian or Indian strain antigens. This phe- 
nomenon has been observed with different strains of other arbor viruses, an indi- 
cation that variations in reactivity with antibody, in the absence of antigenic 
variation, are another factor which must be reckoned with in the interpretation 
of serologic tests. 
Virus Characterization by tteterologous Antibody Absorption.--It  became ap- 
parent  early in our studies that a  considerable degree of specificity could be 
imposed upon an immune serum by absorption with a  heterologous group B 
virus. Such absorbed sera could then be used for the rapid identification of new 
isolates ff these possessed the property of hemagglutination. D. H. CLARKE  25 
The following study was carried out with immune sera prepared against three 
strains of dengue, the absorption being made, in each case, with the Egypt 101 
strain of West Nile virus. The sera were prepared against the Hawaiian strain of 
type 1 dengue, the New Guinea B strain of type 2 dengue, and a dengue strain 
designated as Tr 1751  which was isolated from a  human case in Trinidad by 
Anderson and his  associates  (12).  The HA antigens  were prepared from the 
above viruses plus West Nile and a virus, P  8640,  isolated from a sick child in 
India by Work and his associates (13). When this study was initiated, the Trini- 
dad virus was known to be a strain of dengue, apparently closely related to type 
2, but knowledge of the Indian virus was limited to the fact that it was a mem- 
TABLE  II 
Comparison of Dengue Strains by Antibody Absorption 
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320  ~  640 





640  640 
80  80 
640  640 








Absorption in each case was with the Egypt 101 strain of West Nile virus. 
Results  expressed  as  the reciprocal of the serum dilution giving complete  inhibition  of 
4 to 8 hemagglutinatlng units of each test antigen. 
* No inhibition at serum dilution of 1  : 20. 
ber of group B. Table II presents the data from a relatively simple experiment 
in which unabsorbed and absorbed sera were tested against the five antigens. It 
can be seen that, following absorption, the group-reactive antibodies detected 
by the West Nile antigen were eliminated while homologous antibody remained 
in significant titer, though lower than that of the unabsorbed serum. It can also 
be seen that the two dengues are related by one or more shared antigens not 
present in West Nile since West Nile was unable to remove all of the antibody 
from dengue 1 serum which was cross-reactive with dengue 2. Finally, the two 
recent isolates from Trinidad and India are dearly shown to be strains of type 2 
dengue. It should be noted that cross-complement-fixation studies carried out 
in these laboratories were in agreement with this interpretation (14). 
Antigenic Analysis of the Japanese B-St. Louis-West Nile Subgroup.mSeveral 
investigators have, in the past, noted that the five viruses comprising this sub- 
group (see Table I) show immunologic relationships demonstrable by various 26  GROUP B  ARTHROPOD-BORNE  VIRUSES 
procedures  (1).  Because of their particularly close  relationship, these viruses 
were subjected to antigenic analysis by the absorbed antibody technique. In 
Table III are presented the results of a series of experiments in which St. Louis 
and Japanese B immune rabbit sera were absorbed with various viruses and the 
absorbed and unabsorbed sera tested against the subgroup antigens. The re- 
sults of absorption of Ilheus immune rabbit serum with one virus are also pre- 
sented. The titer of each unabsorbed serum against each antigen was found to be 
quite reproducible, no variation greater than twofold being encountered. 
The results of absorption were similar with the St. Louis and Japanese B 
sera. In both cases, a significant level of homologous antibody remained regard- 
less of the absorbing virus used. The removal of heterologous antibody, how- 
ever, depended markedly upon the absorbing virus. Absorption of either serum 
TABLE III 
Absorption Analysis of Japanese B-St Louls-West Nile Complex Viruses 
Test antigens 
Absorbing virus  St. Louis serum  Japanese B  serum  Ilheus serum 
West Nile (WN) ......  0]  0  [  0  [ 
CMVE):: x6o  I  o  Murray Valley  ..  160  0  0  0  0 
Japanese  B  OBE) ....  0  0  0 
St. Louis  (SLE) ........ 
Ilheus (I1) .............  160  40  0 /  0  t  0[ 
Yellow fever (YF) ......  D  t  20  0  0  320  80 
Nooe ...................   !32o  i1 o 
10ooooo- 
160  0  0  0  0 
1~01  401  O l  ol  0 I 
no I 160] 40[20 I  o[ 
32O  160  40  4O  0  0 
t280112801640  1320 1320 I 80 
640 40  20  20 
Results expressed  as in Table II. 
with West Nile,  Murray Valley, or Japanese B  eliminated all cross-reactive 
antibody, while only antibody against the Murray Valley virus (known to be 
particularly closely related to Japanese B) remained after absorption of Jap- 
anese B serum with St. Louis. From these results, it may be concluded that, 
although each virus contains a specific antigenic component, there is extensive 
sharing of other antigenic components between Japanese B, Murray Valley, 
West Nile and St. Louis viruses. Of these, the first three are apparently most 
closely related. 
In contrast to these results are those obtained from absorption with Ilheus 
and yellow fever (French neurotropic strain) which appear similarly deficient 
in some of the antigenic components shared by the other viruses. Since yellow 
fever virus is not a member of the subgroup, the results obtained with it were 
not unexpected, but the inadequacy of Ilheus came as something of a surprise. 
By absorption analysis, Ilheus is thus seen to be less closely related to the other 
members of the subgroup on the following grounds: (a) absorption by yellow D. H. CLARKE  27 
fever virus removed all cross-reactive antibody against  Ilheus from both St. 
Louis and Japanese B sera; (b) Ilheus was little if any more effective as an ab- 
sorber of these sera than was yellow fever; (c)  absorption of an Ilheus serum 
with yellow fever virus yielded a  preparation having less subgroup reactivity 
than was true with the other sera although the residual specific (Ilhens) anti- 
body level was high. 
Antigenic Analysis of Strains of Yellow Fever Virus.--It has been a generally 
accepted idea that various strains of yellow fever virus are antigenicaUy identi- 
cal. That this concept might be incorrect was suggested by the work of a visiting 
TABLE IV 
Absorption Analysis of Strains of Ye21ow Fever Virus, Using French Strain Immune Serum 
Test Antigens 
Absorbing strain  African strains 




YF-17 D ............. 
YF-Og  .............. 
American strains 
YF-Be H 70 ......... 
YF-Tr 4754 .......... 
YF-JSS .............. 
West Nile .............. 
FN  As  17 D  I  Og  JSS 
I 
I 
o  I  o  o  o  o 
01  0  0  0  0 
o  E  o  I  o  o  o 
ol  o  o  o 
1 
I 
4o  o 
160  160  160  160  0 
1280  1280  640  3201 
2560  2560 I 5120  5120  1280  1280  None .................. 
American strains 






Results expressed as in Table II. 
investigator to these laboratories, Dr. M. Bruno-Lobo of Brazil, who observed 
that the HI results with human sera obtained with a  JSS strain antigen  (see 
Table I) were consistently inferior to those obtained with other strains such as 
the Asibi, the French or the 17 D  vaccine strains (15). An examination of vari- 
ous strains by antibody absorption was, therefore, undertaken, and it became 
apparent that the JSS strain was, indeed, antigenically defective as compared 
with certain others. Although absorption by the JSS strain of an immune serum 
prepared against the French strain resulted in the removal of more homologous, 
French, antibody than was obtained by absorption with another group B virus 
(West Nile), a significant level of antibody reacting with the French and other 
strains still remained (Table IV). 
It was initially assumed that the JSS was simply an odd variant, but since it 28  GROUP B  ARTHROPOD-BORNE VIRUSES 
was the only American strain among those under study, it was decided to com- 
pare other strains on the basis of their place of origin, America or Africa. Table 
IV presents the data obtained when the same pool of immune mouse serum 
(French) was absorbed with various yellow fever strains with the rather sur- 
prising result that all the American strains were found to be incapable of com- 
pletely removing from an African strain immune serum all antibody detectable 
by any African strain antigen.  It should be noted that although five African 
yellow fever viruses appear to be represented, including the French strain pro- 
ducing the serum, these correspond to only three original isolates, the French 
neurotropic being a mouse-adapted variant of the parent, French, and the 17 D 
a tissue culture variant of the parent, Asibi. However, within the limitations of 
this study, there appears to be a genuine difference between randomly chosen 
strains, depending upon whether they are of African or American origin. 
TABLE  V 
Antigenic Analysis of the 17 D Vaccine Strain of Yellow Fever by Absorption of a 
17 D Immune Serum 
Absorbing strain 
Test antigens 
17 D  FN  Fr  As  ISS 
Asibi (As) ...................  40  0  0  0 
French neurotropic (FN) .....  40  0  0  0 
JSS .........................  80  40  80  0 
None .......................  640  640  1280  640  160 
Results expressed as in preceding tables. 
A comparable converse study has not been carried out in which an American 
yellow fever immune serum prepared in the same way has been studied for the 
possible presence of antibody which cannot be absorbed by African strains. 
However, absorption of a JSS strain immune monkey serum with the French 
neurotropic African virus did remove all homologous, JSS, antibody. Since it is 
quite possible that the pattern of antibody response of the monkey to a single 
small dose of virus may differ significantly from that of the mouse following 
multiple large doses, this is considered to be suggestive but by no means con- 
clusive evidence that  American strains  are truly antigenically defective and 
do not, in turn, have a characteristic "American" antigenic marker. 
The final demonstration of antigenic variation among yellow fever strains was 
with the  17 D  vaccine virus, which was shown to possess an antigenic com- 
ponent absent from other strains, including the parent,  Asibi  (Table V). Ab- 
sorption of a  17 D  immune mouse serum with the American JSS virus showed 
the characteristic failure to remove the  "African" antibody, but neither the D. ~r. CLAgKE  29 
French neurotropic nor the Asibi virus was able to remove residual 17 D anti- 
body. This gain in an antigen on the part of the vaccine strain does not appear 
to have been attended by any demonstrable concomitant loss, since the 17 D 
virus proved capable of removing all detectable antibody from an Asibi immune 
mouse serum in a manner entirely analogous to its effect upon its own, 17 D, 
immune serum. 
It is significant that the alteration in pathogenicity for man of a  strain of 
yellow fever is not necessarily attended by any antigenic modification demon- 
strable by the absorption technique. The French neurotropic vaccine strain is 
one which was freed of its visceral pathogenicity for man by prolonged mouse 
brain adaptation. When this attenuated variant was compared, by cross-ab- 
sorption experiments using both sera, with its parent, French strain, the two 
showed complete antigenic identity. 
DISCUSSION 
The rapid increase in the number of arbor viruses which have been and are 
being isolated has posed the serious problem of how to deal with their classifica- 
tion in any systematic and practical fashion. It is our belief that the single most 
reliable and convenient method for classification of these agents is the one intro- 
duced and developed by Casals (2, 3), which is based on antigenic relationships, 
preferably demonstrated by in ~tro techniques. That antigenic structure can, 
indeed, be a stable property is indicated in the present study. The three strains 
of West Nile virus compared had been obtained from three different countries 
and two different hosts, and their isolations covered a span of 15 years. In addi- 
tion, their passage level in mouse brain ranged from the 2nd to the 35th. Yet, 
despite  their varied histories, no evidence of antigenic dissimilarity was ob- 
tained. Furthermore, although African and American yellow fever strains differ, 
each geographical type appears to maintain a  constant antigenic make-up as 
demonstrated by the fact that, in each case, isolations separated by a period of 
approximately 20 years yielded viruses which behaved in an indistinguishable 
manner. The 17 D vaccine strain presumably acquired its characteristic antigen 
during its subsequent history in tissue culture or the chick embryo. It is well 
recognized that prolonged adaptation of a virus to a tissue or host may result in 
marked alteration of certain biologic properties such as tissue or host patho- 
genicity. Certainly this is true of the French neurotropic yellow fever vaccine 
strain with its 200 to 300 mouse brain passages as compared with the pantropic 
Asibi and French strains which were maintained in monkeys and kept  at low 
mouse passage levels. Yet  no demonstrable antigenic alteration resulted from 
this profound biologic modification. 
A second aspect of the problem of virus classification, and one which promises 
to be more difficult to resolve, is the question of what criteria are needed to jus- 
tify the designation of a new isolate as a discrete entity or as a  variant of a pre- 30  GROUP B ARTIIROPOD-BORNE  VIRUSES 
viously isolated virus. Two extreme stands can be  taken on this question: (a) 
all viruses which can be shown to be antigenically related should be considered 
as variants of one virus; (b) any reasonably marked antigenic variation justifies 
the designation of such a virus as a separate entity. (Proponents of these points 
of view have been described, respectively, as "lumpers" and "splitters.") The 
application of absorption analysis to such viruses as those making up the Jap- 
anese B-West Nile--St.  Louis complex yields results which appear to explain 
why each is recognizably different, because of the possession of a specific anti- 
gen, as well as why serologic  overlaps have been encountered, because of the 
prevalence of shared antigens. However, it is of interest that there is an identi- 
cal degree of antigenic difference, as judged by residual antibody titers after 
absorption, between Japanese B and Murray Valley or West Nile, on the one 
hand, and an African (French) strain of yellow fever and an American (JSS) 
strain, on the other (Tables III and IV). Yet, Japanese B, Murray Valley and 
West Nile are generally accepted as distinct viruses while the difference between 
African and American yellow fever previously went unrecognized. It is apparent 
from the same tables that the extent of removal of heterologous antibodies from 
St. Louis, Japanese B, and Ilheus sera by a distantly related virus (yellow fever) 
is generally somewhat greater than is the converse removal of "American" an. 
tibodies from an African strain immune serum by the distantly related West 
Nile virus. Apparently, when the level of shared antigens is sufficiently high, 
conventional serologic  procedures may fail to distinguish between two viruses 
even though the more sensitive technique of absorption analysis reveals con- 
sistent differences. Furthermore, conventional serologic techniques vary in their 
specificity. For example, Smith found the HI and complement-fixation tests 
unreliable for distinguishing between dengue and Japanese B following dengue 
infections in Malaya and considered only the neutralization test sufficiently 
specific  (16);  Goldblum found, however, that the neutralization test gave simi- 
lar results with West Nile and Japanese B viruses following West Nile infections 
in Israel and considered the complement-fixation test the procedure of choice 
(17). Although at the present time it seems impossible to assess the full signifi- 
cance of these similarities and differences, it would appear necessary ultimately 
to resolve the problem of classification in a manner which will be meaningful 
and useful to all of those concerned with arbor viruses and the diseases caused 
by them. Absorption analysis appears to provide more detailed knowledge of 
the antigenic structure of these viruses than any other technique so far utilized. 
Such information would seem to be essential to the development of any scheme 
of classification, although it may be that more than one approach will be neces- 
sary and that antigenic structure will have to be related to other viral properties 
in order to realize an entirely satisfactory picture. 
The demonstration that a rather stable type of antigenic variation may occur 
between different strains of a  virus should prove of value in the selection of D. H. CLARKE  31 
strains for serologic studies and in clarifying our knowledge of the natural his- 
tory of viruses as they occur in different parts of the world. Also, with regard 
to the selection of virus strains for serologic studies, the problem of strain varia- 
tion in avidity for antibodies should be kept in mind.  This was noted in the 
comparison of West Nile strains and is believed to play a role in the poor per- 
formance of the JSS strain of yellow fever as an antigen. Comparative studies 
with human survey sera in our laboratories (14) as well as the data presented 
by Groot and his associates (18) have provided evidence for low avidity as an 
attribute of the JSS antigen. This avidity is presumably unrelated to antigenic 
structure. 
SUMMARY 
A method for carrying out antibody absorption studies for antigenic analysis 
of group B arthropod-borne (arbor) viruses is described and examples d  homolo- 
gous and heterologous absorption curves are presented. Evidence that antigenic 
structure can be a stable property was obtained with three strains of West Nile 
virus isolated from different hosts in different countries over a period of years. 
Comparative  studies  with  viruses  of  the  Japanese  B-St.  Louis-West  Nile 
subgroup indicate that each virus contains a completely specific antigen as well 
as one or more cross-reactive components. Strains of yellow fever virus isolated 
in America were shown to lack an antigen present in strains of Mrican origin 
although no differences were found between isolates from the same geographical 
area. The attenuated 17 D vaccine strain of yellow fever was found to have ac- 
quired an additional antigen not present in the unadapted parent or in other 
strains tested. However, alteration in pathogenicity for man was not found to be 
necessarily attended by any antigenic modification, as shown by the antigenic 
identity of the French neurotropic vaccine strain with its pantropic parent. 
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